Docetaxel versus epirubicin/cyclophosphamide(EC) as first-line therapy in metastatic breast cancer (MBC): results from the randomized phase II TIPP study

被引：0
作者：
不详
机构：
来源：
BREAST | 2005年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [21] Phase II study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Gamucci, Teresa
    D'Ottavio, Anna Maria
    Gareri, Roberta
    Vaccaro, Angela
    Belli, Franca
    Nunziata, Corrado
    Meliffi, Loretta
    Moscetti, Luca
    Barduagni, Mario
    Sperduti, Isabella
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 48 - 49
  • [22] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [23] WEEKLY DOCETAXEL (WEDO) AS FIRST-LINE THERAPY IN ELDERLY METASTATIC BREAST CANCER (MBC)
    Caristi, Nicola
    Maisano, Roberto
    Mare, Marzia
    Chiofalo, Giuseppe
    Picciotto, Maria
    Mafodda, Antonio
    Montalto, Erika
    Zavettieri, Maria
    La Torre, Francesco
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 19 - 20
  • [24] Phase II multicenter sequential study of docetaxel (T) and epirubicin (E) followed by docetaxel (T) and capecitabine (X) as first-line treatment of advanced or metastatic breast cancer (MBC).
    Ramos, M
    Casal, J
    Galán, A
    Almanza, C
    León, L
    Amenedo, M
    Gonzalez, A
    Huidobro, G
    Giner, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 54S - 54S
  • [25] Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer
    Chan, S
    Davidson, N
    Juozaityte, E
    Erdkamp, F
    Pluzanska, A
    Azarnia, N
    Lee, LW
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (10) : 1527 - 1534
  • [26] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Vasey, PA
    Roché, H
    Bisset, D
    Terret, C
    Vernillet, L
    Riva, A
    Ramazeilles, C
    Azli, N
    Kaye, SB
    Twelves, CJ
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (10) : 1072 - 1078
  • [27] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    P A Vasey
    H Roché
    D Bisset
    C Terret
    L Vernillet
    A Riva
    C Ramazeilles
    N Azli
    S B Kaye
    C J Twelves
    [J]. British Journal of Cancer, 2002, 87 : 1072 - 1078
  • [28] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
  • [29] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    [J]. ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [30] Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Lisboa, BW
    Untch, M
    Kuhnle, H
    Janicke, F
    Meerpohl, HG
    Lindner, C
    Kcnecny, G
    Hecker, D
    Diergarten, K
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (01) : S13 - S16
12345